|
Forum di discussione Torna alla Homepage di questo forum - Inserisci un nuovo messaggio |
|
SxcGQVUbgLYrUis Autore: Fritz What's the current interest rate for personal loans? <a href=" https://diverseabilities.org.uk/extend-plus-pills.pdf#expectations ">extend plus pills mg</a> Immunocore has created what it calls "a world-leading platform of bi-specific biological drugs", called ImmTACs. They "exploit the power of T cell receptors to recognise intracellular changes that occur during cancer or viral infection". The Oxford-based firm will receive up to £142 million in pre-clinical milestone payments across the targets and for each product that reaches the market, up to £200 million is due to Immunocore, plus up to double-digit royalties. |
|
Rispondi |